Vector-borne diseases (VBDs) represent a significant public health concern in India, with an increasing burden on the healthcare system. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, include malaria, dengue, chikungunya, and zika, among others. This article provides a comprehensive overview of the current challenges and potential strategies to address VBDs in India.
The Indian subcontinent's diverse climatic conditions and high population density create an ideal environment for the proliferation of vectors, leading to a high incidence of VBDs. Rapid urbanization, poor sanitation, and climate change further exacerbate the situation. According to the World Health Organization, India accounts for 89% of South-East Asia's malaria burden and 34% of dengue cases worldwide.
The primary challenges in addressing VBDs in India include inadequate surveillance, lack of public awareness, insufficient vector control measures, and limited access to healthcare services. Furthermore, the emergence of vector resistance to insecticides and pathogen resistance to drugs pose significant hurdles.
Effective VBD management necessitates a multi-pronged approach. Strengthening surveillance systems for early detection and prompt response, improving public health infrastructure, and enhancing community awareness are crucial. Additionally, integrated vector management strategies, including biological control measures and the judicious use of insecticides, are needed. Research and development in novel diagnostic tools, vaccines, and therapeutics should be prioritized.
The rising challenge of VBDs in India calls for concerted efforts from healthcare professionals, policymakers, researchers, and the community. While the task is daunting, adopting comprehensive, sustainable, and evidence-based strategies can significantly mitigate the impact of these diseases on public health. Continuing professional education and interdisciplinary collaboration will be key to navigating this complex landscape.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation